Recommendations on the utilization of telemedicine in cardiology.

Cardiac implantable electronic devices Heart failure Remote monitoring Telerehabilitation

Journal

Wiener klinische Wochenschrift
ISSN: 1613-7671
Titre abrégé: Wien Klin Wochenschr
Pays: Austria
ID NLM: 21620870R

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 23 06 2020
accepted: 19 10 2020
pubmed: 2 12 2020
medline: 22 12 2020
entrez: 1 12 2020
Statut: ppublish

Résumé

The enormous progress made in recent years in the field of information and communication technology and also in sensor and computer technology has affected numerous fields of medicine and is capable of inducing even radical changes in diagnostic and therapeutic processes. This is particularly true for cardiology, where, for example, telemetric monitoring of cardiac and circulatory functions has been in use for many years. Nevertheless, broad application of newer telemedical processes has not yet been achieved to the extent one would expect from the encouraging results of numerous clinical studies in this field and the state of the art of the underlying technology. In the present paper, the Working Group on Rhythmology of the Austrian Cardiological Society aims to provoke a critical discussion of the digital change in cardiology and to make recommendations for the implementation of those telemedical processes that have been shown to exert positive effects on a wide variety of medical and economic parameters. The greatest benefit of telecardiological applications is certainly to be found in the long-term care of patients with chronic cardiovascular diseases. Accordingly, follow-up care of patients with cardiological rhythm implants, management of chronic heart failure and secondary prevention following an acute cardiac event during rehabilitation are currently the most important fields of application. Telemedicine is intended to enable high-quality and cost-efficient care for an increasing number of patients, whose care poses one of the greatest challenges to our healthcare system. Not least of all, telemedicine should make a decisive contribution to improving the quality of life of this segment of the population by favorably influencing mortality, morbidity and hospitalization as well as the patient's contribution to treatment.

Identifiants

pubmed: 33259003
doi: 10.1007/s00508-020-01762-2
pii: 10.1007/s00508-020-01762-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

782-800

Références

Wilkins E, Wilson L, Wickramasinghe K, et al. European cardiovascular disease statistics 2017. Brussels: European Heart Network; 2017.
Atlas Writing Group, Timmis A, Townsend N, Gale C, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2017. Eur Heart J. 2018;39:508–79. https://doi.org/10.1093/eurheartj_ehx628 .
doi: 10.1093/eurheartj_ehx628
Gruska M. Telemedizin in der Kardiologie. J Kardiol. 2009;16:66–70.
Schwamm LH, Chumbler N, Brown E, et al. Recommendations for the implementation of telehealth in cardiovascular and stroke care: a policy statement from the American Heart Association. Circulation. 2017;135:e24–e44. https://doi.org/10.1161/cir.0000000000000475 .
doi: 10.1161/cir.0000000000000475 pubmed: 27998940
Frederix I, Caiani EG, Dendale P, et al. ESC e‑Cardiology Working Group Position Paper: overcoming challenges in digital health implementation in cardiovascular medicine. Eur J Prev Cardiol. 2019;26:1166–77. https://doi.org/10.1177/2047487319832394 .
doi: 10.1177/2047487319832394 pubmed: 30917695
Stockburger M, Helms TM, Perings CA, et al. Nutzenbewertung des strukturierten Telemonitorings mithilfe von aktiven Herzrhythmusimplantaten. Kardiologe. 2017;11:452–9. https://doi.org/10.1007/s12181-017-0203-8 .
doi: 10.1007/s12181-017-0203-8
Helms TM, Müller A, Perings C, et al. Das Telemedizinische Zentrum als essenzieller Baustein konzeptioneller Ansätze zum Telemonitoring kardialer Patienten. Herzschrittmacherther Elektrophysiol. 2017;28:293–302. https://doi.org/10.1007/s00399-017-0527-x .
doi: 10.1007/s00399-017-0527-x pubmed: 28840312
Helms TM, Stockburger M, Köhler F, et al. Grundlegende Strukturmerkmale eines kardiologischen Telemedizinzentrums für Patienten mit Herzinsuffizienz und implantierten Devices, Herzrhythmusstörungen und erhöhtem Risiko für den plötzlichen Herztod. Herzschrittmacherther Elektrophysiol. 2019;30:136–42. https://doi.org/10.1007/s00399-018-0606-7 .
doi: 10.1007/s00399-018-0606-7 pubmed: 30637467
Helms TM, Stockburger M, Köhler F, et al. Positionspapier Telemonitoring. Herzschrittmacherther Elektrophysiol. 2019;30:287–97. https://doi.org/10.1007/s00399-019-0630-2 .
doi: 10.1007/s00399-019-0630-2 pubmed: 31278607
WHO. A health telematics policy in support of WHO’s Health-For-All strategy for global health development: report of the WHO group consultation on health telematics. 11–16 December 1997; Geneva. Geneva: World Health Organization; 1998.
WHO. Global Observatory for eHealth. Telemedicine: opportunities and developments in Member States: report on the second global survey on eHealth. Geneva: World Health Organization; 2010.
Pagliari C, Sloan D, Gregor P, et al. What is eHealth (4): a scoping exercise to map the field. J Med Internet Res. 2005;7(1):e9. https://doi.org/10.2196/jmir.7.1.e9 .
doi: 10.2196/jmir.7.1.e9 pubmed: 15829481 pmcid: 1550637
Istepanian RSH, Pattichis SC, Laxmiinarayan S. Ubiquitous mHealth systems and the convergence towards 4G mobile technologies. In: Istepanian RSH, Pattichis SC, Laxmiinarayan S, editors. M‑health: emerging mobile health systems. London: Springer; 2006. pp. 3–14.
doi: 10.1007/0-387-26559-7_1
Europäische Kommission. 219 final: Grünbuch über Mobile-Health-Dienste. Brüssel: Europäische Kommission. COM; 2014.
Rodriguez AC, Roda C, Gonzalez P, et al. Contextualizing tasks in telerehabilitation systems for older people. In: International workshop on ambient assisted living. Cham: Springer; 2015. pp. 29–41.
Brennan DM, Tindall L, Theodoros D, et al. A blueprint for telerehabilitation guidelines-October 2010. Telemed J E Health. 2011;17:662–5. https://doi.org/10.1089/tmj.2011.0036 .
doi: 10.1089/tmj.2011.0036 pubmed: 21790271
Rybak K. Telemedizin in der Überwachung und Nachsorge von Herzschrittmachern und Systemen zur Kardialen Resynchronisationstherapie (CRT). In: Goss F, Middeke M, Mengden T, al, editors. Praktische Telemedizin in Kardiologie und Hypertensiologie. Stuttgart: Springer; 2009. pp. 58–77.
Varma N, Epstein AE, Irimpen A, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos‑T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010;122:325–32. https://doi.org/10.1161/circulationaha.110.937409 .
doi: 10.1161/circulationaha.110.937409 pubmed: 20625110
Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013(15):1070–1011. https://doi.org/10.1093/europace/eut206 .
Mabo P, Victor F, Bazin P, et al. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur Heart J. 2012;33:1105–11. https://doi.org/10.1093/eurheartj/ehr419 .
doi: 10.1093/eurheartj/ehr419 pubmed: 22127418
Crossley GH, Chen J, Choucair W, et al. Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. J Am Coll Cardiol. 2009;54:2012–9. https://doi.org/10.1016/j.jacc.2009.10.001 .
doi: 10.1016/j.jacc.2009.10.001 pubmed: 19926006
Shanmugam N, Boerdlein A, Proff J, et al. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population. Europace. 2012;14:230–7. https://doi.org/10.1093/europace/eur293 .
doi: 10.1093/europace/eur293 pubmed: 21933802
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891–975. https://doi.org/10.1002/ejhf.592 .
doi: 10.1002/ejhf.592
Slotwiner D, Varma N, Akar JG, et al. HRS Expert Consensus Statement on remote interrogation and moni-toring for cardiovascular implantable electronic devices. Heart Rhythm. 2015;12:e69–e100. https://doi.org/10.1016/j.hrthm.2015.05.008 .
doi: 10.1016/j.hrthm.2015.05.008 pubmed: 25981148
Varma N, Piccini J, Snell J, et al. The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients. J Am Coll Cardiol. 2015;65:2601–10. https://doi.org/10.1016/j.jacc.2015.04.033 .
doi: 10.1016/j.jacc.2015.04.033 pubmed: 25983008
Capucci A, de Simone A, Luzi M, et al. Economic impact of remote monitoring after implantable defibrillators implantation in heart failure patients: an analysis from the EFFECT study. Europace. 2017;19:1493–9. https://doi.org/10.1093/europace/eux017 .
doi: 10.1093/europace/eux017 pubmed: 28407139
Ladapo JA, Turakhia MP, Ryan MP, et al. Health Care Utilization and Expenditures Associated with remote monitoring in patients with implantable cardiac devices. Am J Card. 2016;117:1455–62. https://doi.org/10.1016/j.amjcard.2016.02.015 .
doi: 10.1016/j.amjcard.2016.02.015 pubmed: 26996767
Boriani G, Da Costa A, Quesada A, et al. Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial. Eur J Heart Fail. 2017;19:416–25. https://doi.org/10.1002/ejhf.626 .
doi: 10.1002/ejhf.626 pubmed: 27568392
Santini M, Gasparini M, Landolina M, et al. Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. J Am Coll Cardiol. 2011;57:167–72. https://doi.org/10.1016/j.jacc.2010.08.624 .
doi: 10.1016/j.jacc.2010.08.624 pubmed: 21211688
Crossley GH, Boyle A, Vitense H, et al. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol. 2011;57:1181–9. https://doi.org/10.1016/j.jacc.2010.12.012 .
doi: 10.1016/j.jacc.2010.12.012 pubmed: 21255955
Guédon-Moreau L, Lacroix D, Sadoul N, et al. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J. 2013;34:605–14. https://doi.org/10.1093/eurheartj/ehs425 .
doi: 10.1093/eurheartj/ehs425 pubmed: 23242192
Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014;384:583–90.
doi: 10.1016/S0140-6736(14)61176-4
Vamos M, Nyolczas N, Bari Z, et al. Refined heart failure detection algorithm for improved clinical reliability of Optivol alerts in CRT‑D recipients. Card J. 2018;25:236–44. https://doi.org/10.5603/cj.a2017.0077 .
doi: 10.5603/cj.a2017.0077
Boehmer JP, Hariharan R, Devecchi FG, et al. A multisensor algorithm predicts heart failure events in patients with implanted devices: results from the multiSENSE study. JACC Heart Fail. 2017;5:216–25. https://doi.org/10.1016/j.jchf.2016.12.011 .
doi: 10.1016/j.jchf.2016.12.011 pubmed: 28254128
Leclercq C, Burri H, Curnis A, et al. Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study: results from Phase I. Eur Heart J. 2019;40:2979–87. https://doi.org/10.1093/eurheartj/ehz109 .
doi: 10.1093/eurheartj/ehz109 pubmed: 30859220
Hindricks G, Elsner C, Piorkowski C, et al. Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial. Eur Heart J. 2014;35:98–105. https://doi.org/10.1093/eurheartj/eht207 .
doi: 10.1093/eurheartj/eht207 pubmed: 23868932
Saxon LA, Hayes DL, Gilliam FR, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation. 2010;122:2359–67. https://doi.org/10.1161/circulationaha.110.960633 .
doi: 10.1161/circulationaha.110.960633 pubmed: 21098452
Akar JG, Bao H, Jones PW, et al. Use of remote monitoring is associated with lower risk of adverse outcomes among patients with implanted cardiac defibrillators. Circ Arrhythm Electrophysiol. 2015;8:1173–80. https://doi.org/10.1161/circep.114.003030 .
doi: 10.1161/circep.114.003030 pubmed: 26092577
Mittal S, Piccini J, Snell J, et al. Improved surivival in patients enrolled promptly into remote monitoring following cardiac electronic device implantation. J Interv Card Electrophysiol. 2016;46:129–36. https://doi.org/10.1007/s10840-016-0112-y .
doi: 10.1007/s10840-016-0112-y pubmed: 26860839 pmcid: 4923102
Parthiban N, Esterman A, Mahajan R, et al. Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes. J Am Coll Cardiol. 2015;65:2591–600. https://doi.org/10.1016/j.jacc.2015.04.029 .
doi: 10.1016/j.jacc.2015.04.029 pubmed: 25983009
García-Fernández FJ, Osca-Asensi J, Romero R, et al. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE). Eur Heart J. 2019;40:1837–46. https://doi.org/10.1093/eurheartj/ehz067 .
doi: 10.1093/eurheartj/ehz067 pubmed: 30793735 pmcid: 6568206
Brignole M, Vardas P, Hoffman E, et al. Indications for the use of diagnostic implantable and external ECG loop recorders. Europace. 2009;11:671–87. https://doi.org/10.1093/europace/eup097 .
doi: 10.1093/europace/eup097 pubmed: 19401342
Bloch Thomsen PE, Jons C, Raatikainen MJ, et al. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study. Circulation. 2010;122:1258–64. https://doi.org/10.1161/circulationaha.109.902148 .
doi: 10.1161/circulationaha.109.902148 pubmed: 20837897
Krahn AD, Klein GJ, Yee R, et al. Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. Am J Cardiol. 1998;82:117–9.
doi: 10.1016/S0002-9149(98)00237-9
Hindricks G, Pokushalov E, Urban L, et al. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: results of the XPECT trial. Circ Arrhythm Electrophysiol. 2010;3:141–7. https://doi.org/10.1161/circep.109.877852 .
doi: 10.1161/circep.109.877852 pubmed: 20160169
Pürerfellner H, Sanders P, Pokushalov E, et al. Miniaturized reveal LINQ insertable cardiac monitoring system: first-in-human experience. Heart Rhythm. 2015;12:1113–9. https://doi.org/10.1016/j.hrthm.2015.02.030 .
doi: 10.1016/j.hrthm.2015.02.030 pubmed: 25728756
Sanders P, Pürerfellner H, Pokushalov E, et al. Performance of a new atrial fibrillation detection algorithm in a miniaturized insertable cardiac monitor: results from the Reveal LINQ Usability Study. Heart Rhythm. 2016;13:1425–30. https://doi.org/10.1016/j.hrthm.2016.03.005 .
doi: 10.1016/j.hrthm.2016.03.005 pubmed: 26961298
Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883–948. https://doi.org/10.1093/eurheartj/ehy037 .
doi: 10.1093/eurheartj/ehy037 pubmed: 29562304
January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019;140:e125–e51.
doi: 10.1161/CIR.0000000000000665
Maines M, Zorzi A, Tomasi G, al at. Clinical impact, safety, and accuracy of the remotely monitored implantable loop recorder Medtronic Reveal LINQ
doi: 10.1093/europace/eux187 pubmed: 29016753
Søgaard P, Behrens S, Konyi A, et al. Transmission and loss of ECG snapshots: Remote monitoring in implantable cardiac monitors. J Electrocardiol. 2019;56:24–8. https://doi.org/10.1016/j.jelectrocard.2019.06.005 .
doi: 10.1016/j.jelectrocard.2019.06.005 pubmed: 31233982
Eurlings CGMJ, Boyne JJ, de Boer RA, et al. Telemedicine in heart failure-more than nice to have? Neth Heart J. 2019;27:5–15. https://doi.org/10.1007/s12471-018-1202-5 .
doi: 10.1007/s12471-018-1202-5 pubmed: 30536146
Cowie MR, Bax J, Bruining N, et al. e‑Health: a position statement of the European Society of Cardiology. Eur Heart J. 2016;37:63–6. https://doi.org/10.1093/eurheartj/ehv416 .
doi: 10.1093/eurheartj/ehv416 pubmed: 26303835
Von der Heidt A, Ammenwerth E, Bauer K, et al. HerzMobil Tirol network: rationale for and design of a collaborative heart failure disease management program in Austria. Wien Klin Wochenschr. 2014;126:734–41. https://doi.org/10.1007/s00508-014-0665-7 .
doi: 10.1007/s00508-014-0665-7 pubmed: 25392254
Modre-Osprian R, Poelzl G, Von Der Heidt A, et al. Closed-loop healthcare monitoring in a collaborative heart failure network. Stud Health Technol Inform. 2014;198:17–24. https://doi.org/10.3233/978-1-61499-397-1-17 .
doi: 10.3233/978-1-61499-397-1-17 pubmed: 24825680
Ammenwerth E, Fetz B, Gstrein S, et al. Herzmobil, an integrated and collaborative telemonitoring-based disease management program for patients with heart failure: a feasibility study paving the way to routine care. JMIR Cardio. 2018;2:e11. https://doi.org/10.2196/cardio.9936 .
doi: 10.2196/cardio.9936 pubmed: 31758765 pmcid: 6857958
Poelzl G, Fetz B, Altenberger J, et al. Heart failure disease management programs in Austria 2019—a systematic survey of the Heart Failure Working Group and the Working Group for Cardiological Assistance and Care Personnel of the Austrian Society of Cardiology. Wien Klin Wochenschr. 2020; https://doi.org/10.1007/s00508-020-01615-y .
doi: 10.1007/s00508-020-01615-y pubmed: 32072313 pmcid: 7297701
Koehler F, Koehler K, Deckwart O, et al. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. Lancet. 2018;392:1047–57. https://doi.org/10.1016/s0140-6736(18)31880-4 .
doi: 10.1016/s0140-6736(18)31880-4 pubmed: 30153985
Nigls SC, Clark RA, Dierckx R, et al. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev. 2015; https://doi.org/10.1002/14651858.cd007228.pub3 .
doi: 10.1002/14651858.cd007228.pub3
Seferovic PM, Ponikowski P, Anker SD, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21:1169–86. https://doi.org/10.1002/ejhf.1531 .
doi: 10.1002/ejhf.1531 pubmed: 31129923
Wagenaar KP, Broekhuizen BDL, Jaarsma T, et al. Effectiveness of the European Society of Cardiology/Heart Failure Association website ‘heartfailurematters.org’ and an e‑health adjusted care pathway in patients with stable heart failure: results of the ‘e-Vita HF’ randomized controlled trial. Eur J Heart Fail. 2019;21:238–46. https://doi.org/10.1002/ejhf.1354 .
doi: 10.1002/ejhf.1354 pubmed: 30485612
Abraham WT, Stevenson LW, Bourge RC, et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete followup results from the CHAMPION randomised clinical trial. Lancet. 2016;387:453–61. https://doi.org/10.1016/s0140-6736(11)60101-3 .
doi: 10.1016/s0140-6736(11)60101-3 pubmed: 26560249
Eggerth A, Modre-Osprian R, Hayn D, et al. Comparison of body weight trend algorithms for prediction of heart failure related events in home care setting. Stud Health Technol Inform. 2017;236:219–26. https://doi.org/10.3233/978-1-61499-759-7-219 .
doi: 10.3233/978-1-61499-759-7-219 pubmed: 28508799
Moertl D, Altenberger J, Bauer N, et al. Disease management programs in chronic heart failure: position statement of the Heart Failure Working Group and the Working Group of the Cardiological Assistance and Care Personnel of the Austrian Society of Cardiology. Wien Klin Wochenschr. 2017;129:869–78. https://doi.org/10.1007/s00508-017-1265-0 .
doi: 10.1007/s00508-017-1265-0 pubmed: 29080104 pmcid: 5711993
Oldridge N, Pakosh M, Grace SL. A systematic review of recent cardiac rehabilitation meta-analyses in patients with coronary heart disease or heart failure. Future Cardiol. 2019;15:227–49. https://doi.org/10.2217/fca-2018-0085 .
doi: 10.2217/fca-2018-0085 pubmed: 31161796
Pack QR, Goel K, Lahr BD, et al. Participation in cardiac rehabilitation and survival after coronary artery bypass graft surgery: a community-based study. Circulation. 2013;128:590–7. https://doi.org/10.1161/circulationaha.112.001365 .
doi: 10.1161/circulationaha.112.001365 pubmed: 23836837
Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23:636–48. https://doi.org/10.1177/2047487315569401 .
doi: 10.1177/2047487315569401 pubmed: 25687109
Gyimesi M, Fülöp G, Ivansits S, et al. Rehabilitationsplan. Wien: Gesundheit Österreich; 2016.
Mampuya WM. Cardiac rehabilitation past, present and future: an overview. Cardiovasc Diagn Ther. 2012;2:38–49. https://doi.org/10.3978/j.issn.2223-3652.2012.01.02 .
doi: 10.3978/j.issn.2223-3652.2012.01.02 pubmed: 24282695 pmcid: 3839175
Janssen V, De Gucht V, van Exel H, et al. Beyond resolutions? A randomized controlled trial of a self-regulation lifestyle programme for post-cardiac rehabilitation patients. Eur J Prev Cardiol. 2013;20:431–41. https://doi.org/10.1177/2047487312441728 .
doi: 10.1177/2047487312441728 pubmed: 22396248
Brouwers RW, Kraal JJ, Traa SC, et al. Effects of cardiac telerehabilitation in patients with coronary artery disease using a personalised patient-centred web application: protocol for the SmartCare-CAD randomised controlled trial. BMC Cardiovasc Disord. 2017;17:46–57. https://doi.org/10.1186/s12872-017-0477-6 .
doi: 10.1186/s12872-017-0477-6 pubmed: 28143388 pmcid: 5282829
Galea MD. Telemedicine in rehabilitation. Phys Med Rehabil Clin N Am. 2019;30:473–83. https://doi.org/10.1016/j.pmr.2018.12.002 .
doi: 10.1016/j.pmr.2018.12.002 pubmed: 30954160
Frederix I, Solmi F, Piepoli MF, et al. Cardiac telerehabilitation: a novel cost-efficient care delivery strategy that can induce long-term health benefits. Eur J Prev Cardiol. 2017;24:1708–17. https://doi.org/10.1177/2047487317732274 .
doi: 10.1177/2047487317732274 pubmed: 28925749
Thorup CB, Grønkjær M, Spindler H, et al. Pedometer use and self-determined motivation for walking in a cardiac telerehabilitation program: a qualitative study. BMC Sports Sci Med Rehabil. 2016;8:24. https://doi.org/10.1186/s13102-016-0048-7 .
doi: 10.1186/s13102-016-0048-7 pubmed: 27547404 pmcid: 4991060
Frederix I, Vandijck D, Hens N, et al. Economic and social impact of increased cardiac rehabilitation uptake and cardiac telerehabilitation in Belgium—a cost-benefit analysis. Acta Cardiol. 2017;73:222–9. https://doi.org/10.1080/00015385.2017.1361892 .
doi: 10.1080/00015385.2017.1361892 pubmed: 28799460
Hwang R, Bruning J, Morris NR, et al. Home-based telerehabilitation is not inferior to a centre-based program in patients with chronic heart failure: a randomised trial. J Physiother. 2017;63:101–7. https://doi.org/10.1016/j.jphys.2017.02.017 .
doi: 10.1016/j.jphys.2017.02.017 pubmed: 28336297
Piotrowicz E, Baranowski R, Bilinska M, et al. A new model of home-based telemonitored cardiac rehabilitation in patients with heart failure: effectiveness, quality of life, and adherence. Eur J Heart Fail. 2010;12:164–71. https://doi.org/10.1093/eurjhf_hfp181 .
doi: 10.1093/eurjhf_hfp181 pubmed: 20042423
Piotrowicz E, Zieliski T, Bodalski R, et al. Home-based telemonitored Nordic walking training is well accepted, safe, effective and has high adherence among heart failure patients, including those with cardiovascular implantable electronic devices: a randomised controlled study. Eur J Prev Cardiol. 2015;22:1368–77. https://doi.org/10.1177/2047487314551537 .
doi: 10.1177/2047487314551537 pubmed: 25261268
Nouryan C, Morahan S, Pecinka K, et al. Home telemonitoring of community dwelling heart failure patients after home care discharge. Telemed J E Health. 2019;25:447–54. https://doi.org/10.1089/tmj.2018.0099 .
doi: 10.1089/tmj.2018.0099 pubmed: 30036166
Momsen AH, Hald K, Nielsen CV, et al. Effectiveness of expanded cardiac rehabilitation in patients diagnosed with coronary heart disease: a systematic review protocol. JBI Database System Rev Implement Rep. 2017;15:212–9. https://doi.org/10.11124/jbisrir-2016-003265 .
doi: 10.11124/jbisrir-2016-003265 pubmed: 28178014
Fors A, Swedberg K, Ulin K, et al. Effects of personcentred care after an event of acute coronary syndrome: two-year follow-up of a randomised controlled trial. Int J Cardiol. 2017;249:42–7. https://doi.org/10.1016/j.ijcard.2017.08.069 .
doi: 10.1016/j.ijcard.2017.08.069 pubmed: 28893432
Müller A, Rybak K, Klingenheben T, et al. Empfehlungen zum Telemonitoring bei Patienten mit implantierten Herzschrittmachern, Defibrillatoren und kardialen Resynchronisationssystemen. Kardiologe. 2017;7:181–93. https://doi.org/10.1007/s12181-013-0496-1 .
doi: 10.1007/s12181-013-0496-1
Slotwiner DJ, Abraham RL, Al-Khatib SM, et al. HRS White Paper on interoperability of data from cardiac implantable electronic devices (CIEDs). Heart Rhythm. 2019;16:e107–e27. https://doi.org/10.1016/j.hrthm.2019.05.002 .
doi: 10.1016/j.hrthm.2019.05.002 pubmed: 31077801
Slotwiner DJ, Tarakji KG, Al-Khatib SM. Transparent sharing of digital health data: a call to action. Heart Rhythm. 2019;16:e95–e106. https://doi.org/10.1016/j.hrthm.2019.04.042 .
doi: 10.1016/j.hrthm.2019.04.042 pubmed: 31077802
EU Commission. European interoperability framework—implementation strategy, annex 2. COM; 2017. 134 final, Brussels, 23.3.2017.
EU Commission. Recommendation on a European Electronic Health Record exchange format. Brussels, 2019. (C(2019)800).
EU Commission. Commission Decision 2015/1302 of 28 July 2015 on the identification of ‘Integrating the Healthcare Enterprise’ profiles for referencing in public procurement. Brussels, 2015.
Sauermann S. Rahmenrichtlinie für die IT-Infrastruktur bei der Anwendung von Telemonitoring. Wien: BMGAS; 2018.
IEEE/ISO/CEN 11073. Health informatics—Point-of-care medical device communication.
Heidbuchel H, Hindricks G, Broadhurst P, et al. EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring. Eur Heart J. 2015;36:158–69. https://doi.org/10.1093/eurheartj_ehu339 .
doi: 10.1093/eurheartj_ehu339 pubmed: 25179766
Klersy C, Boriani G, De Silvestri A, et al. Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta-analysis of randomized controlled trials in patients with heart failure. Eur J Heart Fail. 2016;18:195–204. https://doi.org/10.1002/ejhf.470 .
doi: 10.1002/ejhf.470 pubmed: 26817628
Hindricks G, Varma N, Kacet S, et al. Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST). Eur Heart J. 2017;38:1749–55. https://doi.org/10.1093/eurheartj/ehx015 .
doi: 10.1093/eurheartj/ehx015 pubmed: 29688304 pmcid: 5461472

Auteurs

Michael Gruska (M)

Hauptstelle-Abt. Forschung, Innovation, Leistungsentwicklung, Pensionsversicherungsanstalt, Friedrich Hillegeist-Straße 1, 1021, Vienna, Austria. michael.gruska@pv.at.

Gerhard Aigner (G)

Institut für Ethik und Recht in der Medizin, Universität Wien, Spitalgasse 2-4, Hof 2.8, 1090, Vienna, Austria.

Johann Altenberger (J)

SKA-Rehabilitationszentrum Großgmain, Salzburger Straße 520, 5084, Großgmain, Austria.

Dagmar Burkart-Küttner (D)

2. Med. Abteilung, Hanusch Krankenhaus, Heinrich-Collin-Straße 30, 1140, Vienna, Austria.

Lukas Fiedler (L)

2. Interne Abteilung, Landesklinikum Wr. Neustadt, Corvinusring 3-5, 2700, Wiener Neustadt, Austria.

Marianne Gwechenberger (M)

Universitätsklinik für Innere Medizin II, Klinische Abteilung für Kardiologie, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Peter Lercher (P)

Klinische Abteilung für Kardiologie, Medizinische Universität Graz, Auenbruggerplatz 15, 8036, Graz, Austria.

Martin Martinek (M)

2. Interne Abteilung, Ordensklinikum Linz, Krankenhaus der Elisabethinen, Fadingerstraße 1, 4020, Linz, Austria.

Michael Nürnberg (M)

3. Medizinische Abteilung, Wilheminenspital der Stadt Wien, Montleartstraße 37, 1160, Vienna, Austria.

Gerhard Pölzl (G)

Universitätsklinik für Innere Medizin III, Medizinische Universität Innsbruck, Anichstraße, 6020, Innsbruck, Austria.

Gerold Porenta (G)

Privatkrankenanstalt Rudolfinerhaus, Billrothstraße 78, 1190, Vienna, Austria.

Stefan Sauermann (S)

Medical Engineering & eHealth, FH Technikum Wien, Höchstädtplatz 6, 1200, Vienna, Austria.

Christoph Schukro (C)

Universitätsklinik für Innere Medizin II, Klinische Abteilung für Kardiologie, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Daniel Scherr (D)

Klinische Abteilung für Kardiologie, Medizinische Universität Graz, Auenbruggerplatz 15, 8036, Graz, Austria.

Clemens Steinwender (C)

Klinik für Kardiologie und internistische Intensivmedizin, Med Campus III, Kepler Universitätsklinikum, Krankenhausstraße 9, 4021, Linz/Donau, Austria.

Markus Stühlinger (M)

Universitätsklinik für Innere Medizin III, Medizinische Universität Innsbruck, Anichstraße, 6020, Innsbruck, Austria.

Alexander Teubl (A)

2. Interne Abteilung, Landesklinikum Wr. Neustadt, Corvinusring 3-5, 2700, Wiener Neustadt, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH